Filtered By:
Management: Food and Drug Administration (FDA)
Nutrition: Organic
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 51 results found since Jan 2013.
As Ebola Deaths Climb, Organic Activists Line Up Against Medical Cure
As the death toll from Ebola continues to rise, especially in the hard-hit West African countries of Liberia, Sierra Leone and Guinea, the need for a viable treatment or cure is growing increasingly urgent.
Fears that the pandemic might escalate have prompted the World Health Organization (WHO) to announce a crash project to come up with an Ebola vaccine. At least seven different vaccines are in development. One major worry is that any vaccine, if approved, may not be widely available for several months--June at the earliest.
But there is another growing concern among health officials: As often happens in times of medic...
Source: Healthy Living - The Huffington Post - November 3, 2014 Category: Consumer Health News Source Type: news
Janssen Presents Results from Phase 3 ACIS Study in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with ERLEADA ® (apalutamide) and ZYTIGA® (abiraterone acetate) Combination
RARITAN, N.J., February 8, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the randomized, double-blind, placebo-controlled Phase 3 ACIS study, which met the primary endpoint of radiographic progression-free survival (rPFS) with a 31 percent reduction in the risk of radiographic progression or death in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) receiving androgen deprivation therapy (ADT). Patients in the trial received either a combination of ERLEADA® and ZYTIGA® plus prednisone (combination arm) or placebo and ZYTIGA® pl...
Source: Johnson and Johnson - February 8, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
How Jennifer Doudna ’s Life Has Changed Since Discovering CRISPR 10 Years Ago
Jennifer Doudna was staring at a computer screen filled with a string of As, Cs, Ts, and Gs—the letters that make up human DNA—and witnessing a debilitating genetic disease being cured right before her eyes. Just a year earlier, in 2012, she and microbiologist Emmanuelle Charpentier had published a landmark paper describing CRISPR-Cas9, a molecular version of autocorrect for DNA, and she was seeing one the first demonstrations of CRISPR’s power to cure a human disease. She was in the lab of Dr. Kiran Musunuru, a Harvard researcher who was eager to show her the results from an experiment he had just finish...
Source: TIME: Health - July 1, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized feature Genetics healthscienceclimate Source Type: news
ERLEADA ® (apalutamide) Oral Presentations Demonstrate Importance of Prostate Specific Antigen (PSA) as Key Efficacy Indicator and Show Strong Patient Adherence Rates
September 11, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data demonstrating robust prostate-specific antigen (PSA) response and strong adherence rates in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) treated with ERLEADA® (apalutamide) in the real-world clinical setting. The strong PSA response was also seen in a separate post-hoc analysis that showed a correlation between rapid and deep PSA response and prolonged survival in both metastatic castration-sensitive prostate cancer (mCSPC) and nmCRPC. The post-hoc analysis also suppor...
Source: Johnson and Johnson - September 12, 2021 Category: Pharmaceuticals Source Type: news
FDA Adds More Drugs To Valsartan Recall List
(CNN) — The US Food and Drug Administration again added to its list of products that are included in the recall of drugs containing valsartan, a generic ingredient that helps people with high blood pressure and heart failure. That ingredient in the recalled drugs was tainted with a possible carcinogen.
The FDA testing of these products determined that an additional lot of brands sold under the name RemedyRepack needed to be added to the recall list.
See The Full List Here (PDF)
Several pills that contain valsartan have been under a voluntary recall since July. The drugs were tainted with N-nitrosodimethylamine, or ND...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - October 25, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Local TV Valsartan Source Type: news
Blood Pressure Medication Recall Expands Again To Include Losartan
(CNN) — A widespread recall of common blood pressure and heart failure medications has been expanded to include more drugs containing losartan. The recall is due to an “impurity” that is classified as a potential human carcinogen.
The impurity, N-Nitroso-N-methyl-4-aminobutyric acid or NMBA, is also classified as a known animal carcinogen, the US Food And Drug Administration noted in a news release about the recall Friday.
Camber Pharmaceuticals Inc. voluntarily recalled 87 lots of losartan tablets in the United States on Thursday. The recalled tablets, made by Hetero Labs Ltd. In India and distributed by...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 1, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Consumer Health News FDA losartan Valsartan Source Type: news
Scientists devise method to prevent deadly hospital infections without antibiotics
A hospital or medical clinic might be the last place you ’d expect to pick up a nasty infection, but approximately 1.7 million Americans do each year, resulting in nearly 100,000 deaths from infection-related complications and roughly $30 billion in direct medical costs.The biggest culprits, experts say — accounting for two-thirds of these infections — are medical devices like catheters, stents, heart valves and pacemakers, whose surfaces often become covered with harmful bacterial films. But a novel surface treatment developed by a UCLA-led team of scientists could help improve the safety of t hese devices and ease ...
Source: UCLA Newsroom: Health Sciences - May 19, 2022 Category: Universities & Medical Training Source Type: news
Bioproduction of the Recombinant Sweet Protein Thaumatin: Current State of the Art and Perspectives
Jewel Ann Joseph1,2,3, Simen Akkermans1,2,3, Philippe Nimmegeers1,2,3 and Jan F. M. Van Impe1,2,3*
1BioTeC+, Chemical and Biochemical Process Technology and Control, Department of Chemical Engineering, KU Leuven, Leuven, Belgium
2Optimization in Engineering Center-of-Excellence, KU Leuven, Leuven, Belgium
3CPMF2, Flemish Cluster Predictive Microbiology in Foods, Leuven, Belgium
There is currently a worldwide trend to reduce sugar consumption. This trend is mostly met by the use of artificial non-nutritive sweeteners. However, these sweeteners have also been proven to have adverse health effects such as dizzines...
Source: Frontiers in Microbiology - April 7, 2019 Category: Microbiology Source Type: research
How Michael Jung ’s team created a drug to extend the lives of men with prostate cancer
Fifteen years ago, Michael Jung was already an eminent scientist when his wife asked him a question that would change his career, and extend the lives of many men with a particularly lethal form of prostate cancer.“When I turned 55 — I’m now 70 — my wife, Alice, said to me, ‘What do you want to do for the rest of your life, more of the same?’” recalled Jung, a UCLA distinguished professor of chemistry and biochemistry. “I said that didn’t sound like such a bad idea until you put it that wa y.”“I really thought seriously,” said Jung, who at the time was an organic chemist who designed new synthetic...
Source: UCLA Newsroom: Health Sciences - March 16, 2018 Category: Universities & Medical Training Source Type: news
Janssen Demonstrates Commitment to Advancing Science and Innovation in the Treatment of Solid Tumors at ESMO Annual Congress
September 8, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than ten data presentations from its lung cancer, bladder cancer and prostate cancer portfolio and pipeline will be featured during the European Society for Medical Oncology (ESMO) Annual Congress 2021 virtual meeting, September 16–21. Further details about these data and the science Janssen is advancing will be made available throughout ESMO via the Janssen Oncology Virtual Newsroom.“With a diverse oncology portfolio and pipeline spanning bladder cancer, lung cancer and prostate cancer, Janssen...
Source: Johnson and Johnson - September 8, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
More than Cosmetic Changes: Taking Stock of Personal Care Product Safety
Joe Greco, principal scientist in beauty care product development for Johnson & Johnson, works on reformulating an acne gel cleanser. Johnson & Johnson is one of several companies investing considerable resources to remove specific chemicals from their products.© Rebecca Kessler
An infographic prepared by the PCPC lays out the order of events and estimated timeframe for reformulating products.© Personal Care Products Council
In 2013 Johnson & Johnson completed reformulation of about 100 baby products, a process that involved approximately 1,500 prototypes. Some prototyp...
Source: EHP Research - May 1, 2015 Category: Environmental Health Authors: Web Admin Tags: Featured Focus News Allergies and Policy Chemical Sensitivities Chemical Testing Children's Health Endocrine Disruptors Health Disparities Industry Issues Laws May 2015 Organic Farming and Products Personal Care Products Regu Source Type: research
Hickory Harvest Recalls Certain Island Fruit Mix and Organic Nut Mix Products Because of Possible Health Risk
Hickory Harvest Foods of Akron, Ohio is voluntarily recalling specific lots due to the potential exposure to Listeria monocytogenes. Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, pregnant women, and others with weakened immune systems. Healthy individuals may experience short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain, and diarrhea. Listeria infection can also cause miscarriages, stillbirths, and fetal infection in pregnant women. People experiencing these problems should seek immediate medical attention.
Source: Food and Drug Administration - May 19, 2018 Category: Food Science Source Type: news
Is Honey Healthy? Here ’s What Experts Say
Because it comes from nature — from bees, no less — honey has a health halo. But is honey really healthy? Here’s what dietitians say about the health benefits of honey.
What is honey made of?
Honey is made from nectar. “Bees collect the dilute-sugary nectar of flora plants, produce an enzymatic activity after ingestion, regurgitate it into honey cells and evaporate a high percentage of the water out of it, producing a super-sweet viscous liquid known as honey,” explains Dana Hunnes, a senior dietitian at Ronald Reagan UCLA Medical Center.
The sweet substance is mostly fructose and glucose &mda...
Source: TIME: Health - April 16, 2019 Category: Consumer Health News Authors: Cassie Shortsleeve Tags: Uncategorized Diet/Nutrition Source Type: news
Janssen to Highlight Depth of Solid Tumor Portfolio at ASCO GU
RARITAN, N.J., February 3, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today multiple data presentations from a robust solid tumor portfolio that will be featured at the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium, taking place February 13-15 in San Francisco. Company-sponsored data presentations will include clinical results for ERLEADA® (apalutamide) and niraparib in prostate cancer; and BALVERSA™ (erdafitinib) in bladder cancer. “We are committed to improving outcomes in patients with prostate and bladder cancer where high unmet needs continue...
Source: Johnson and Johnson - February 3, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news
Researcher Studies Statins for Stroke Therapy
Stacy Pigott
A $2.8 million grant may help develop an improved therapeutic treatment for acute ischemic stroke patients to let them recover faster with fewer long-term complications. The protocol hinges on effectively delivering statins to the brain, where their neuroprotective properties can help save tissue damaged by stroke.
Aug. 7, 2020
University of Arizona Health Sciencesnhg-PATRICK-RONALDSON_DSC6492-web.jpg
Patrick Ronaldson (right), associate professor in the College of Medicine – Tucson's Department of Pharmacology, and doctoral students Erica Williams and Robert Betterton discuss their latest researc...
Source: The University of Arizona: Health - August 6, 2020 Category: Universities & Medical Training Authors: mittank Source Type: research
